August 01, 2015 – News Bytes

Drug Sponsors

Teva to acquire Allergan Generics for $40.5B, withdraws proposal to acquire Mylan

Teva Pharmaceutical Industries, based in Israel, has signed a definitive agreement with Allergan to acquire Allergan Generics for $40.5 billion.


The Pulse on Site Success by Jeffrey Adelglass

Tracking recruitment efforts can become increasingly complex as efforts expand in today’s multifaceted field of patient recruitment, yet tracking is key to developing metrics.


More Pulse articles... »

CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.